Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data
Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy
Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity
Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer
Transplanted tumor growth and the incidence of T-lymphocyte populations in the spleen of newcastle virus-treated mice
Cancer immunotherapy: dendritic-cell vaccines on the move
Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models
A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
Immunotherapy for lung cancer: for whom the bell tolls?
Dendritic cell-based vaccine efficacy: aiming for hot spots
Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell